Cite

HARVARD Citation

    Martins, F. et al. (n.d.). 33PCombination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer. Annals of oncology. p. . [Online]. 
  
Back to record